Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik D Brady

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Continuing Education in Nursing|October 29, 2015
Writing Multiple Choice Outcome Questions to Assess Knowledge and CompetenceErik D Brady
Discovery Medicine|August 14, 2010
Antibody guided precision radiation therapyErik D Brady, Diane E Milenic, Martin W Brechbiel
Nature Reviews. Drug Discovery|June 3, 2004
Antibody-targeted radiation cancer therapyDiane E Milenic, Erik D Brady, Martin W Brechbiel
Journal of the Advanced Practitioner in Oncology|October 19, 2018
The SMARTIE Program: A Novel Initiative to Evaluate the Impact of AP Continuing Education on Clinical PracticeSandra E Kurtin, Constance Visovsky, Erik D Brady, et al.
Nuclear Medicine and Biology|July 13, 2004
Development of a spectroscopic assay for bifunctional ligand-protein conjugates based on copperErik D Brady, Hyun-Soon Chong, Diane E Milenic, et al.
Nuclear Medicine and Biology|April 12, 2005
Purification of cyclotron-produced 203Pb for labeling HerceptinKayhan Garmestani, Diane E Milenic, Erik D Brady, et al.
Journal of the American Chemical Society|June 13, 2002
A mechanistic study of the samarium(II)-mediated reduction of aryl nitro compounds to the corresponding crylamines. The crystal structures of [Sm[N(SiMe(3))(2)](2)(thf)](2)(mu(2)-O) and [(Me(3)Si)(2)N](2)Sm(thf)(mu-PhNNPh)Sm[N(SiMe(3))(2)](2)Erik D Brady, David L Clark, D Webster Keogh, et al.
Cancer|February 4, 2010
Improved efficacy of alpha-particle-targeted radiation therapy: dual targeting of human epidermal growth factor receptor-2 and tumor-associated glycoprotein 72Diane E Milenic, Erik D Brady, Kayhan Garmestani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
Potentiation of high-LET radiation by gemcitabine: targeting HER2 with trastuzumab to treat disseminated peritoneal diseaseDiane E Milenic, Kayhan Garmestani, Erik D Brady, et al.
Nuclear Medicine and Biology|May 25, 2006
In vitro and in vivo evaluation of novel ligands for radioimmunotherapyHyun-Soon Chong, Diane E Milenic, Kayhan Garmestani, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Continuing Education in Nursing|October 29, 2015
Writing Multiple Choice Outcome Questions to Assess Knowledge and CompetenceErik D Brady
Discovery Medicine|August 14, 2010
Antibody guided precision radiation therapyErik D Brady, Diane E Milenic, Martin W Brechbiel
Nature Reviews. Drug Discovery|June 3, 2004
Antibody-targeted radiation cancer therapyDiane E Milenic, Erik D Brady, Martin W Brechbiel
Journal of the Advanced Practitioner in Oncology|October 19, 2018
The SMARTIE Program: A Novel Initiative to Evaluate the Impact of AP Continuing Education on Clinical PracticeSandra E Kurtin, Constance Visovsky, Erik D Brady, et al.
Nuclear Medicine and Biology|July 13, 2004
Development of a spectroscopic assay for bifunctional ligand-protein conjugates based on copperErik D Brady, Hyun-Soon Chong, Diane E Milenic, et al.
Nuclear Medicine and Biology|April 12, 2005
Purification of cyclotron-produced 203Pb for labeling HerceptinKayhan Garmestani, Diane E Milenic, Erik D Brady, et al.
Journal of the American Chemical Society|June 13, 2002
A mechanistic study of the samarium(II)-mediated reduction of aryl nitro compounds to the corresponding crylamines. The crystal structures of [Sm[N(SiMe(3))(2)](2)(thf)](2)(mu(2)-O) and [(Me(3)Si)(2)N](2)Sm(thf)(mu-PhNNPh)Sm[N(SiMe(3))(2)](2)Erik D Brady, David L Clark, D Webster Keogh, et al.
Cancer|February 4, 2010
Improved efficacy of alpha-particle-targeted radiation therapy: dual targeting of human epidermal growth factor receptor-2 and tumor-associated glycoprotein 72Diane E Milenic, Erik D Brady, Kayhan Garmestani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
Potentiation of high-LET radiation by gemcitabine: targeting HER2 with trastuzumab to treat disseminated peritoneal diseaseDiane E Milenic, Kayhan Garmestani, Erik D Brady, et al.
Nuclear Medicine and Biology|May 25, 2006
In vitro and in vivo evaluation of novel ligands for radioimmunotherapyHyun-Soon Chong, Diane E Milenic, Kayhan Garmestani, et al.
Pageof 2